Key result
Computer-assisted laser densitometry (CALD) was 100% accurate in retrospective blind studies of 351 samples and provided highly accurate carrier risk in >90% of over 800 women from D/BMD families.
Why the study?
Does computer-assisted laser densitometry accurately determine carrier status for Duchenne/Becker muscular dystrophy in at-risk females?
Observational (n=1,151)
Blinded
Does computer-assisted laser densitometry accurately determine carrier status for Duchenne/Becker muscular dystrophy in at-risk females?
Computer-assisted laser densitometry provides a highly accurate method for determining carrier status in females at risk for Duchenne and Becker muscular dystrophies.
Answers are grounded in this paper and cite their sources.
Supports accurate D/BMD carrier risk assessment with CALD; leaves open prospective validation before clinical adoption.
Carrier status determination for Duchenne and Becker muscular dystrophies (D/BMD), disorders caused by mutations in the dystrophin gene at Xp21, is complicated by a number of factors. These include a high mutation rate and a 5-10% recombination frequency across the dystrophin gene. For these reasons, linkage analysis frequently gives an inconclusive result, and a direct mutation detection method for females at risk is desirable. Because 65% of the mutations that cause D/BMD are deletions of one or more exons of the dystrophin gene, diagnosis in most affected males is relatively easy using multiplex polymerase chain reaction (PCR) analysis. However, deletion analysis in females is more difficult because of the interference of the normal X chromosome in the deletion assay. We have developed a quantitative PCR-based analysis designated computer-assisted laser densitometry (CALD), which uses the automated fluorescent fragment analysis application of the Applied Biosystems (Foster City, California) automated sequencer. This method has proved to be 100% accurate in retrospective blind studies analysing a total of 351 samples. Subsequent analysis of more than 800 women from more than 400 D/BMD families has shown that a highly accurate carrier risk can be given in more than 90% of cases.
No takes yet. Share an insight, caveat, or question.
Allingham‐Hawkins et al. (1998) conducted an observational in Duchenne and Becker muscular dystrophies (D/BMD) (n=1,151). Computer-assisted laser densitometry (CALD) was evaluated on Accuracy of carrier status determination. Computer-assisted laser densitometry (CALD) was 100% accurate in retrospective blind studies of 351 samples and provided highly accurate carrier risk in >90% of over 800 women from D/BMD families.
Synapse has enriched 10 related papers. Consider them for comparative context: